Spero Therapeutics
Price & Volume
Stats
See moreOpen | $2.53 |
Previous Close | $2.55 |
Day Range | $2.48-$2.55 |
52W Range | $0.62-$3.22 |
Market Cap | $148.2M |
Shares Short | 737,720 |
Financials
See moreRevenue (12 Mos) | $66.8M |
Revenue Growth (YoY) | 174.5% |
Gross Profit (12 Mos) | $28.3M |
Diluted EPS | $0.15 |
News
See moreYahoo Finance • 2 months ago
Spero Therapeutics Non-GAAP EPS of $0.53, revenue of $41.3M
Yahoo Finance • 2 months ago
Spero Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results and Provide Business Update on March 26, 2026
Yahoo Finance • 3 months ago
Airgain And 2 Other Promising Penny Stocks
Yahoo Finance • 5 months ago
Spero Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
About
CEO | Ms. Esther P. Rajavelu |
CFO | Ms. Esther P. Rajavelu |
Address | 675 Massachusetts Avenue, Cambridge, MA, United States, 02139 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 25 |